UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-A

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

 

Apollo Medical Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware	46-3837784
(State of incorporation or organization)	(I.R.S. Employer Identification No.)
700 N. Brand Blvd., Suite 1400, Glendale, CA	91203
(Address of principal executive offices)	(Zip Code)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class		Name of each exchange on which
to be so registered		each class is to be registered
Common Stock, $0.001 par value per share		The NASDAQ Stock Market LLC

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. x

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. ¨

 

Securities Act registration statement file number to which this form relates:         333-219898       (if applicable).

 

Securities to be registered pursuant to Section 12(g) of the Act:

 

None

(Title of class)

 

 

 

NFORMATION REQUIRED IN REGISTRATION STATEMENT

 

Item 1. Description of Registrant’s Securities to be Registered.

 

A description of common stock, par value $0.001 per share (the “Common Stock”), of Apollo Medical Holdings, Inc., a Delaware corporation (the “Registrant”), to be registered is set forth under the heading “Description of ApolloMed Capital Stock” in the joint proxy statement/prospectus included in the Registrant’s Registration Statement on Form S-4 (File No. 333-219898), initially filed with the Securities and Exchange Commission (the “Commission”) on August 11, 2017, as subsequently amended (the “Registration Statement”), and is incorporated herein by reference.

 

The form of joint proxy statement/prospectus filed by the Registrant on November 15, 2017 pursuant to Rule 424(b) under the Securities Act of 1933, as amended, that constitutes part of the Registration Statement, shall be deemed incorporated herein by reference.

 

The Registrant’s Common Stock to be registered hereunder has been approved for listing on the NASDAQ Capital Market of The NASDAQ Stock Market LLC under the symbol “AMEH.”

 

Item 2. Exhibits.

 

Under the “Instructions as to Exhibits” with respect to Form 8-A, no exhibits are required to be filed with this registration statement because no other securities of the Registrant are registered with The NASDAQ Stock Market LLC and the Registrant’s Common Stock registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

  

 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

	APOLLO MEDICAL HOLDINGS, INC.
Date: December 7,  2017
	By:	/s/ Warren Hosseinion
	Name:	Warren Hosseinion
	Title:	Chief Executive Officer